The addition of highly effective modulator therapies (HEMTs), namely Elexacaftor/Ivacaftor/Tezacaftor (Trikafta), has presented nutrition challenges in people with cystic fibrosis. This workshop examines current research on HEMTs and how they relate to nutrition status in people with CF. Speakers discuss changes in the gastrointestinal microbiome, inflammation, absorption, and growth parameters as a result of Trikafta use.
Originally recorded November 3, 2023.
NACFC 2023 | W24: Modulators and Nutrition
Теги
cystic fibrosisCFcysticfibrosisCystic Fibrosis FoundationCFFCF Foundationcff.orgNACFCNorth American Cystic Fibrosis ConferenceNorth American CF ConferenceNACFC 2023modulatorsCFTR modulatorTrikaftahighly effective modulatorinflammationGIgastrointestinalnutritionmicrobiomeliver diseaseNicole GreenJulie SanvilleAmber JamesKasey WilburnJennifer Duong
